1st Apr 2021 14:02
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 31 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,773,973 | 1.38% | 190,301 | 0.15% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
102,359 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
1,882,432 | 1.46% | 203,467 | 0.16% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 4 | 229.6500 USD |
| Purchase | 13 | 229.5400 USD |
| Purchase | 14 | 230.1628 USD |
| Purchase | 16 | 230.4893 USD |
| Purchase | 30 | 229.7313 USD |
| Purchase | 32 | 230.0350 USD |
| Purchase | 55 | 229.8284 USD |
| Purchase | 58 | 230.1282 USD |
| Purchase | 60 | 230.1621 USD |
| Purchase | 67 | 230.9545 USD |
| Purchase | 80 | 229.4520 USD |
| Purchase | 80 | 230.2510 USD |
| Purchase | 81 | 230.0872 USD |
| Purchase | 87 | 229.4667 USD |
| Purchase | 89 | 230.2313 USD |
| Purchase | 90 | 230.1737 USD |
| Purchase | 91 | 229.5369 USD |
| Purchase | 98 | 229.5215 USD |
| Purchase | 100 | 230.3139 USD |
| Purchase | 104 | 229.5672 USD |
| Purchase | 108 | 229.6728 USD |
| Purchase | 118 | 229.8454 USD |
| Purchase | 122 | 230.1952 USD |
| Purchase | 127 | 229.3987 USD |
| Purchase | 141 | 228.8841 USD |
| Purchase | 157 | 231.4218 USD |
| Purchase | 195 | 230.3582 USD |
| Purchase | 400 | 230.0550 USD |
| Purchase | 600 | 229.7841 USD |
| Purchase | 600 | 230.7150 USD |
| Purchase | 667 | 229.7760 USD |
| Purchase | 719 | 229.5278 USD |
| Purchase | 739 | 230.7087 USD |
| Purchase | 890 | 230.1356 USD |
| Purchase | 1,723 | 231.1736 USD |
| Purchase | 1,957 | 230.7135 USD |
| Purchase | 2,089 | 229.4919 USD |
| Purchase | 2,506 | 230.1002 USD |
| Purchase | 2,585 | 229.7057 USD |
| Purchase | 2,621 | 231.0747 USD |
| Purchase | 3,106 | 229.1179 USD |
| Purchase | 3,465 | 229.8535 USD |
| Purchase | 4,331 | 230.6815 USD |
| Purchase | 5,058 | 230.1223 USD |
| Purchase | 6,564 | 230.2552 USD |
| Purchase | 13,467 | 228.8800 USD |
| Purchase | 35,591 | 229.5541 USD |
| Sale | 1 | 229.4700 USD |
| Sale | 4 | 229.6500 USD |
| Sale | 40 | 229.1100 USD |
| Sale | 100 | 230.7800 USD |
| Sale | 100 | 230.6900 USD |
| Sale | 229 | 231.8270 USD |
| Sale | 244 | 229.3830 USD |
| Sale | 1,483 | 231.2884 USD |
| Sale | 1,780 | 230.1356 USD |
| Sale | 2,270 | 229.9417 USD |
| Sale | 3,660 | 229.0388 USD |
| Sale | 4,761 | 230.4526 USD |
| Sale | 5,013 | 230.1822 USD |
| Sale | 5,165 | 229.8169 USD |
| Sale | 6,848 | 230.3999 USD |
| Sale | 10,000 | 230.7982 USD |
| Sale | 14,367 | 228.8800 USD |
| Sale | 36,590 | 229.4444 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 1 Apr 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210401005507/en/
Copyright Business Wire 2021
Related Shares:
Barclays